| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |